Company / Operating Income
Wave Life Sciences Ltd. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$215.4M
FY2025
5-year range
-$215.4M / -$68.0M
FY2021-FY2025
Trend
-95.1%
vs FY2024
Sector context
#149 of 204
Health Care
What the data says
At -$215M, Wave Life Sciences Ltd.'s operating income ranks #149 of 204 in the Health Care sector. Operating Income has fluctuated over the past 10 years, ranging from -$215M in FY2025 to -$56M in FY2016.
Based on SEC 10-K filings.
-$215M in FY2025.
Declined from -$68M to -$215M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#149 of 204 in Health CareTop 73% of 204This company -$215.4M Sector average $107.7M
▼
-299.9% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 95.1% year-over-year.
- Ranks #149 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$215.4M | -95.1% |
| FY2024 | -$110.4M | -62.4% |
| FY2023 | -$68.0M | +46.5% |
| FY2022 | -$127.0M | +17.2% |
| FY2021 | -$153.4M | +26.4% |
| FY2020 | -$208.3M | -103.5% |
| FY2019 | -$102.4M | +35.8% |
| FY2018 | -$159.5M | -55.8% |
| FY2017 | -$102.4M | -83.8% |
| FY2016 | -$55.7M | -1459.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026